Top member reports
Straws
Sort by:
Recent
Content is delayed by one month. Upgrade your membership to unlock all content. Click for membership options.
#Revises FY24 Guidance
Some key points in commentary:
- Made significant changes to its sales organisation with the consolidation of its sales leadership, implementation of a unified field strategy for its XBIOTM product suite and the restructuring of its DME1 sales force and go-to-market strategy.
- Recent sales results have been below expectations with the transition taking longer than originally forecast.
- Due to the uncertainty created by the sales transformation, the Board has decided to remove revenue guidance for FY24.
